SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe E. who wrote (5281)9/9/1998 5:05:00 PM
From: Izzy   of 6136
 
Besides the buyout rumors, AGPH's fundamentals look excellent. Book value is $7.65; Price/Book Value is only 3.66; debt to equity ratio is 2.5 (acceptable). Is it the general consensus that AGPH will easily beat the estimated EPS ($0.22) for the quarter ending 9/98 (scheduled to be reported 10-14-98)? And, any further discussion on how shareholders should vote regarding splitting the company? And, does anyone think that AGPH will buyout IMNR. My guess, if AGPH is to be bought out, is that it won't happen until 1999, once all other business has been completed. Personally, I would not even consider selling any of my shares for <40.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext